Dasatinib inhibits primary melanoma cell proliferation through morphologydependent disruption of SrcERK signaling

Author:        

Publisher: Spandidos Publications

ISSN: 1792-1074

Source: Oncology Letters, Vol.5, Iss.2, 2013-01, pp. : 527-532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract